NCT00234910View on ClinicalTrials.gov

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2008

Conditions
HIV Infection
Interventions
DRUG

Tenofovir DF

TDF 300mg QD for 72 wks

DRUG

lopinavir/ritonavir with 2 Nucleoside RTIs

LPV/rSGC 400/100mg BID + 2 nucleoside RTIs as prescribed by the Investigator for 72 wks

Trial Locations (1)

60064

Global Medical Information-Abbott, Abbott Park

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY